Clinical Trials Browser

Hydatidiform Mole, Invasive × Methotrexate × 1 year × Clear all

NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Phase NA Active not recruiting

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease